Ridgemont Equity Partners, a buyout and growth equity investor, announced the acquisition of American Outcomes Management (“AOM” or the “Company”), a leading specialty infusion provider focused on intravenous immunoglobulin (“IVIG”) infusion therapy. Financial terms of the transaction were not disclosed.
AOM provides home-based IVIG therapy to patients with over 80 different chronic conditions, with long-term treatment administered by skilled infusion nurses. The Company also provides support services, including pharmacy services, referral management, insurance verification and patient education and training. AOM was founded in 1994 and holds pharmacy licenses in all 50 states.
“Specialty infusion services have been a focus area for Ridgemont for many years,” said Petri Lindberg, Principal at Ridgemont. “It is a very large and growing market, driven by an aging population suffering from chronic conditions, a significant pipeline of specialty infusion drugs and increased adoption of at-home treatment. AOM is a scaled platform with a strong market position, best-in-class reputation in multiple key metro areas and dedicated focus on high quality infusion services. We are excited to partner with Chris York, a seasoned executive with decades of experience in the home infusion sector and longtime operating advisor to Ridgemont.”
“AOM has a tremendous growth opportunity ahead and several avenues for expansion,” said Chris York, Chairman of AOM. “Our vision for the business starts with investing in our team and capabilities to expand our presence in all geographic markets and offer additional specialty infusion therapies. Infusion services continue to shift out of the hospital setting towards alternative sites as patients, providers and payors prefer the comfort and cost-effectiveness of at-home treatment. With Ridgemont’s support, AOM can broaden its reach and help more people in our communities find long-term care solutions.”
About American Outcomes Management
American Outcomes Management (“AOM” or the “Company”) provides home-based intravenous immunoglobulin (“IVIG”) therapy to patients with over 80 different chronic conditions, with long-term treatment administered by skilled infusion nurses. The Company also provides support services, including pharmacy services, referral management, insurance verification and patient education and training. AOM was founded in 1994 and holds pharmacy licenses in all 50 states. www.americanoutcomes.com
About Ridgemont Equity Partners
Ridgemont Equity Partners is a Charlotte-based middle market buyout and growth equity investor. Since 1993, the principals of Ridgemont have invested over $5.5 billion. The firm focuses on equity investments up to $250 million and utilizes a proven, industry-focused investment approach and repeatable value creation strategies. www.ridgemontep.com
The M&A market for healthcare companies continues to strengthen in 2022 ahead of projected increases in US capital gains taxes. There is unprecedented capital in market, the lowest interest rates in US history and strong acquirer motivations for high quality healthcare companies. Across the continuum of care, buyers and investors are looking for well established, profitable businesses and offering strong valuations and options for management.
Do you know the current market value of your business? We do! We are here to help you plan, prepare, explore and succeed in executing your strategic options.
Contact Paragon Ventures for more information.
800-719-1555
